I agree that this site is using cookies. You can find further informations here.
X
Akard, Luke P.
51  results:
Search for persons X
?
1

Impact of Public Reporting of Center-Specific Survival Anal..:

Sharma, Akshay ; Logan, Brent ; Estrada-Merly, Noel...
Transplantation and Cellular Therapy.  29 (2023)  8 - p. 523-528 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Impact of Public Reporting of Center-Specific Analysis Scor..:

Sharma, Akshay ; Logan, Brent ; Estrada-Merly, Noel...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S182 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Integration of Publicly Reported Center Outcomes into Stand..:

LeMaistre, Charles F. ; Wacker, Kara K. ; Akard, Luke P....
Biology of Blood and Marrow Transplantation.  25 (2019)  11 - p. 2243-2250 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Effect of Aging and Predonation Comorbidities on the Relate..:

Pulsipher, Michael A. ; Logan, Brent R. ; Chitphakdithai, Pintip...
Biology of Blood and Marrow Transplantation.  25 (2019)  4 - p. 699-711 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Improving Outcomes in Chronic Myeloid Leukemia Over Time in..:

Chopade, Pradnya ; Akard, Luke P.
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  11 - p. 710-723 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and..:

Caldemeyer, Lauren E. ; Akard, Luke P. ; Edwards, John R....
Biology of Blood and Marrow Transplantation.  23 (2017)  11 - p. 1989-1997 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Exploratory study on the impact of switching to nilotinib i..:

Ailawadhi, Sikander ; Akard, Luke P. ; Miller, Carole B....
Therapeutic Advances in Hematology.  8 (2016)  1 - p. 3-12 , 2016
Link: https://doi.org/10.1177/..
 
?
8

Evaluating the Impact of a Switch to Nilotinib on Imatinib-..:

Cortes, Jorge E. ; Lipton, Jeffrey H. ; Miller, Carole B....
Clinical Lymphoma Myeloma and Leukemia.  16 (2016)  5 - p. 286-296 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Rationale and motivating factors for treatment-free remissi..:

Caldemeyer, Lauren ; Akard, Luke P.
Leukemia & Lymphoma.  57 (2016)  12 - p. 2739-2751 , 2016
Link: https://doi.org/10.1080/..
 
?
10

Translating Trial-Based Molecular Monitoring Into Clinical ..:

Akard, Luke P. ; Wang, Y. Lynn
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  5 - p. 385-395 , 2011
Link: https://doi.org/10.1016/..
 
?
11

Transportation of peripheral blood progenitor cell products..:

Jansen, Jan ; Nolan, Pamela L. ; Reeves, Margaret I....
Cytotherapy.  12 (2010)  7 - p. 919-923 , 2010
Link: https://doi.org/10.3109/..
 
?
12

Transportation of peripheral blood progenitor cell products..:

Jansen, Jan ; Nolan, Pamela L. ; Reeves, Margaret I....
Cytotherapy.  11 (2009)  1 - p. 79-85 , 2009
Link: https://doi.org/10.1080/..
 
?
13

Starting granulocyte–colony‐stimulating factor (filgrastim)..:

Thompson, James M. ; Carlton, Pam ; Akard, Luke P...
Transfusion.  49 (2009)  3 - p. 548-554 , 2009
Link: https://doi.org/10.1111/..
 
?
14

Effects of extensive splenomegaly in patients with myelofib..:

Ciurea, Stefan O. ; Sadegi, Barry ; Wilbur, Andrew...
British Journal of Haematology.  141 (2008)  1 - p. 80-83 , 2008
Link: https://doi.org/10.1111/..
 
?
15

Prediction of engraftment after autologous peripheral blood..:

Jansen, Eva M. ; Hanks, Susan G. ; Terry, Colin...
Transfusion.  47 (2007)  5 - p. 817-823 , 2007
Link: https://doi.org/10.1111/..
 
1-15